Literature DB >> 19274541

Evaluation of histopathological features and pregnancy outcomes of pregnancy associated adnexal masses.

I Türkçüoğlu1, M Mutlu Meydanli, Y Engin-Ustün, Y Ustün, A Kafkasli.   

Abstract

The aim of this study was to evaluate the pathological features and pregnancy outcomes of pregnancy-associated adnexal masses, between 2001 and 2007. During this period, 0.3% of deliveries (35) were associated with adnexal masses. Torsion or rupture of the adnexal mass complicated pregnancy in 17.1% (6/35) of the cases. The most common histopathological diagnosis was dermoid cyst in 40% of cases (14/35), and 8.5% of cases (3/35) were malignant, including borderline ovarian lesion. None of the patients had an adverse pregnancy outcome due to emergency laparotomy. Pregnancy-associated persistent adnexal masses with large size, complex or solid appearance and bilateral location can be managed surgically, which can decrease the risk of complications, such as torsion or rupture and which can diagnose malignancies early.

Entities:  

Mesh:

Year:  2009        PMID: 19274541     DOI: 10.1080/01443610802678804

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

Review 1.  Management of gynecological cancers during pregnancy.

Authors:  Sileny N Han; Magali Verheecke; Tineke Vandenbroucke; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Curr Oncol Rep       Date:  2014-12       Impact factor: 5.075

2.  Robotic-assisted surgery for the treatment of pelvic masses in pregnant patients: a series of four cases and literature review.

Authors:  Alberto A Mendivil; John V Brown; Lisa N Abaid; Mark A Rettenmaier; John P Micha; Marie A Wabe; Bram H Goldstein
Journal:  J Robot Surg       Date:  2013-01-18

3.  Pathological features of persistent adnexal masses in pregnancy.

Authors:  Zhiqiang Zhang; Xiaojuan Zheng; Miao Zhang; Jinfeng Li; Jing Zhao; Jing Zheng; Shuzhen Wang
Journal:  Ann Transl Med       Date:  2021-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.